Total Payments
$2,608
2024 Payments
$1,220
Companies
20
Transactions
91
Medicare Patients
240
Medicare Billing
$50,422
Payment Breakdown by Category
Food & Beverage$2,459 (94.3%)
Travel$149.60 (5.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,459 | 90 | 94.3% |
| Travel and Lodging | $149.60 | 1 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $414.69 | 12 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $275.53 | 9 | $0 (2024) |
| Gilead Sciences, Inc. | $251.71 | 7 | $0 (2018) |
| GlaxoSmithKline, LLC. | $236.75 | 10 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $222.32 | 8 | $0 (2024) |
| Olympus Corporation of the Americas | $203.60 | 2 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $168.18 | 7 | $0 (2024) |
| INOGEN, INC. | $135.51 | 6 | $0 (2024) |
| ABBVIE INC. | $132.04 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $121.95 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,220 | 47 | GlaxoSmithKline, LLC. ($192.11) |
| 2023 | $564.65 | 22 | Actelion Pharmaceuticals US, Inc. ($123.37) |
| 2022 | $67.78 | 3 | Actelion Pharmaceuticals US, Inc. ($36.40) |
| 2020 | $30.00 | 1 | Mylan Specialty L.P. ($30.00) |
| 2019 | $272.02 | 6 | Olympus Corporation of the Americas ($203.60) |
| 2018 | $147.48 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($122.48) |
| 2017 | $306.23 | 10 | Gilead Sciences Inc ($226.71) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 2 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: RESPIRATORY | ||||||
| 06/25/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $23.55 | General |
| 06/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/23/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: Cardiology | ||||||
| 05/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/09/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/05/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $29.31 | General |
| Category: Narcoplepsy | ||||||
| 03/28/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: Cardiology | ||||||
| 03/28/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: IMMUNOLOGY | ||||||
| 03/28/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: VACCINE | ||||||
| 03/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: RESPIRATORY | ||||||
| 03/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: RESPIRATORY | ||||||
| 03/15/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $26.34 | General |
| Category: Narcoplepsy | ||||||
| 03/06/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $27.13 | General |
| Category: Narcoplepsy | ||||||
| 02/27/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Respiratory | ||||||
| 02/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Respiratory | ||||||
| 01/11/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 12/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV | Food and Beverage | In-kind items and services | $31.11 | General |
| 12/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2023 | AbbVie Inc. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 240 | 359 | $158,092 | $50,422 |
Total Patients
240
Total Services
359
Medicare Billing
$50,422
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 98 | 161 | $101,179 | $31,937 | 31.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 77 | 129 | $43,216 | $14,013 | 32.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 33 | $7,331 | $2,384 | 32.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 21 | 23 | $3,069 | $1,060 | 34.5% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 13 | 13 | $3,297 | $1,027 | 31.2% |
About Dr. David Smith, M.D
Dr. David Smith, M.D is a Critical Care Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2011. The National Provider Identifier (NPI) number assigned to this provider is 1538450028.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Smith, M.D has received a total of $2,608 in payments from pharmaceutical and medical device companies, with $1,220 received in 2024. These payments were reported across 91 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,459).
As a Medicare-enrolled provider, Smith has provided services to 240 Medicare beneficiaries, totaling 359 services with total Medicare billing of $50,422. Data is available for 1 year (2023–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Brooklyn, NY
- Active Since 05/02/2011
- Last Updated 09/29/2018
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1538450028
Products in Payments
- OFEV (Drug) $283.55
- UPTRAVI (Drug) $275.53
- Letairis (Drug) $251.71
- WAKIX (Drug) $222.32
- Olympus EBUS Bronchoscopes (Device) $203.60
- ACTHAR (Biological) $198.95
- TRELEGY ELLIPTA (Drug) $166.51
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $135.51
- TEFLARO (Drug) $119.20
- AVYCAZ (Drug) $83.72
- GLASSIA (Biological) $60.33
- Arikayce (Drug) $53.25
- YUPELRI (Drug) $49.55
- NUCALA (Biological) $49.05
- CLEVIPREX (Drug) $32.43
- FASENRA (Biological) $31.73
- WINREVAIR (Biological) $30.05
- Yupelri (Drug) $30.00
- NEPHROCHECK LIQUID CONTROL KIT (Device) $28.38
- TEZSPIRE (Biological) $26.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Brooklyn
Dr. Joshua Rosenberg, M.d, M.D
Critical Care Medicine — Payments: $893,165
Critical Care Medicine $893,165
Dr. Aaliya Burza, M.d, M.D
Critical Care Medicine — Payments: $54,441
Critical Care Medicine $54,441
Dr. Keerthana Keshava, M.b.b.s, M.B.B.S
Critical Care Medicine — Payments: $23,722
Critical Care Medicine $23,722
Dr. Yizhak Kupfer, Md, MD
Critical Care Medicine — Payments: $22,120
Critical Care Medicine $22,120
Mediha Ibrahim, M.d, M.D
Critical Care Medicine — Payments: $14,961
Critical Care Medicine $14,961
Igor Chernyavskiy, M.d, M.D
Critical Care Medicine — Payments: $7,598
Critical Care Medicine $7,598